Method for producing phosphoserine incorporated proteins by using SepRS mutants and EF-Tu mutants
View Patent ↗The present invention relates to a method of producing a phosphorylated protein using a SepRS (O-phosphoseryl-tRNA synthetase) mutant and an EF-Tu mutant, which have increased activity. More specifically, the invention relates to a method of producing a phosphorylated protein by incorporating phosphoserine into the specific position of a target protein or polypeptide using tRNA Sep serving to recognize at least one codon in the mRNA of the target protein or polypeptide, an O-phosphoseryl-tRNA synthetase (SepRS) mutant selected by a molecular evolution technique and serving to aminoacylate tRNA Sep with phosphoserine (Sep), and an EF-Tu mutant serving to bind and deliver Sep-tRNA Sep to the ribosome. According to the invention, a phosphorylated protein can be produced in an amount of mg per liter using the SepRS and EF-Tu mutants. Thus, the invention is useful for the production of various phosphorylated proteins, including phosphorylated enzymes, the production of antibodies, the fabrication of protein chips, and cell-based screening for new drug development.
1. A method of producing a phosphorylated protein by incorporating phosphoserine into the specific position of a target protein or polypeptide, the method comprising expressing an mRNA encoding the target protein in the system using tRNA Sep serving to recognize at least one codon in the mRNA of the target protein or polypeptide, a SepRS mutant serving to aminoacylate tRNA Sep with phosphoserine (Sep), a EF-Tu mutant serving to bind and deliver Sep-tRNA Sep to the ribosome, and the ribosome incorporating the Sep into the specific target protein or polypeptide recognized by the Sep-tRNA sep ,
wherein the SepRS mutant has at least one mutation selected from the group consisting of: K347E, N352D, E412S, E412D, E414I, E414M, E414W, F452L, E481D, P495R, P495S, I496R, I496S, L512I, and V532A in an O-phosphoseryl-tRNA synthetase (SepRS) having the amino acid sequence of SEQ ID NO:17, and
wherein EF-Tu mutant has at least one mutation selected from the group consisting of: H67R, E216V, E216L, E216T, E216A, E216R, E216C, E216Y, D217G, F219Y, T229S, T229A, W274A, and W274N in an EF-Tu having the amino acid sequence of SEQ ID NO:19.
2. The method of claim 1 , wherein the EF-Tu mutant has an amino acid sequence of any one of SEQ ID NOs: 6 to 14.
3. The SepRS mutant of claim 1 , wherein the SepRS mutant has an amino acid sequence of any one of SEQ ID NOs: 1 to 4.
4. The method of claim 1 , wherein the tRNA Sep is derived from Methanocaldococcus jannaschii .
5. The method of claim 4 , wherein the gene encoding the tRNA Sep has a nucleotide sequence set forth in SEQ ID NO: 16.